Summary
GBI Research, a leading
business intelligence provider, has released its latest research report,
"Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving
Treatment Algorithms to Drive Market Growth" Melanoma is a highly
heterogeneous disease comprising Cutaneous Melanoma (CM), Ocular Melanoma (OM),
Mucosal Melanoma (MM), melanoma of the internal organs, and, according to some
classifications, melanoma of the soft parts (non-bony and non-cartilaginous
tissues) of the body. CM is by far the most common form of melanoma, accounting
for approximately 90-95% of all melanomas.
Click for report details:
http://www.radiantinsights.com/research/melanoma-therapeutics-market-to-2020-rising-prevalence-and-evolving-treatment-algorithms-to-drive-market-growth
Historically, melanoma
has been considered as a very challenging disease to treat with
pharmacotherapy. However, in recent years, understanding of the pathophysiology
and heterogeneity of melanoma, and particularly CM, has developed considerably.
This has led to the approval of several new drug agents indicated for CM since
2011, namely Sylatron (peginterferon alfa-2b), Yervoy (ipilimumab), Opdivo,
(nivolumab), Keytruda (pembrolizumab), Zelboraf (vemurafenib), Tafinlar
(dabrafenib) and Mekinist (trametinib). These drugs have dramatically improved
the treatment options for CM patients, leading to unprecedented market
growth.
Rapid market growth is
also anticipated over the forecast period due to the expanding melanoma
treatment population and the continued uptake of recently approved drugs. The
melanoma pipeline is currently strong, with several promising molecules in
development including, Polynoma's seviprotimut-L, Amgen's talimogene
laherparepvec (T-VEC) and Roche and Genentech's cobimetinib in combination with
Zelboraf, which are in development for CM, as well as AstraZeneca's selumetinib
which is in development for OM. Consequently, the melanoma therapeutics market
is projected to grow from $1.3 billion in 2013 to $3.6 billion in 2020, at a
CAGR of 15.4%.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment